Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
News: The Problem Solvers Caucus is endorsing the Dignity Act, a bipartisan immigration proposal that has divided House Republicans.

Problem Solvers back Dignity Act

News: The Problem Solvers Caucus is endorsing the Dignity Act, a bipartisan immigration proposal that has divided House Republicans.

It’s the first time the centrist group has backed the bill under President Donald Trump. The legislation from Rep. Maria Elvira Salazar (R-Fla.) would create a pathway to legal status for undocumented immigrants who have been living in the United States, boost border security and reform asylum-seeker processes.

The Problem Solvers Caucus says the bill would make the immigration system “more secure, orderly, and fair” and reduce the national debt.

Salazar said in a statement that the Problem Solvers’ endorsement “marks a major step forward and reflects a shared commitment to practical, bipartisan solutions.”

The group — co-led by Reps. Brian Fitzpatrick (R-Pa.) and Tom Suozzi (D-N.Y.) — includes dozens of centrist House members on both sides of the aisle.

Some of these Republicans have also been pushing for changes at ICE after federal agents shot and killed two people in Minneapolis earlier this year. But they won’t get any of those reforms in the GOP reconciliation bill that funds ICE and CBP. These moderate Republicans are desperate for bipartisan accomplishments.

Meanwhile, House GOP hardliners have been railing against the Dignity Act. The House Freedom Caucus has bashed it and said the proposal “must die in the cradle” and “undermines the agenda the American people want.”

Presented by Cencora

From accelerating innovation to powering the pharmaceutical supply chain, we reduce barriers to expand access to medications for millions of Americans at sites of care in their communities. Learn more

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by Cencora

From accelerating innovation to powering the pharmaceutical supply chain, we reduce barriers to expand access to medications for millions of Americans at sites of care in their communities. Learn more

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.